465 related articles for article (PubMed ID: 29386886)
1. Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway.
Zhang H; Yang Y; Wang Y; Wang B; Li R
Drug Des Devel Ther; 2018; 12():89-98. PubMed ID: 29386886
[TBL] [Abstract][Full Text] [Related]
2. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
[TBL] [Abstract][Full Text] [Related]
3. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses.
Chen J; Hou XF; Wang G; Zhong QX; Liu Y; Qiu HH; Yang N; Gu JF; Wang CF; Zhang L; Song J; Huang LQ; Jia XB; Zhang MH; Feng L
J Ethnopharmacol; 2016 Dec; 193():433-444. PubMed ID: 27664441
[TBL] [Abstract][Full Text] [Related]
4. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
5. Design and optimization of crocetin loaded PLGA nanoparticles against diabetic nephropathy via suppression of inflammatory biomarkers: a formulation approach to preclinical study.
Yang X
Drug Deliv; 2019 Dec; 26(1):849-859. PubMed ID: 31524015
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice.
Chen H; Yang X; Lu K; Lu C; Zhao Y; Zheng S; Li J; Huang Z; Huang Y; Zhang Y; Liang G
Toxicol Lett; 2017 Aug; 278():48-58. PubMed ID: 28700904
[TBL] [Abstract][Full Text] [Related]
7. Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis.
Xu L; Shen P; Bi Y; Chen J; Xiao Z; Zhang X; Wang Z
Int Immunopharmacol; 2016 Sep; 38():385-94. PubMed ID: 27355131
[TBL] [Abstract][Full Text] [Related]
8. Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling.
Zhao TT; Zhang HJ; Lu XG; Huang XR; Zhang WK; Wang H; Lan HY; Li P
PLoS One; 2014; 9(3):e90807. PubMed ID: 24646636
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats.
Zhao T; Sun S; Zhang H; Huang X; Yan M; Dong X; Wen Y; Wang H; Lan HY; Li P
PLoS One; 2016; 11(1):e0147693. PubMed ID: 26807792
[TBL] [Abstract][Full Text] [Related]
10. Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat.
Lu HJ; Tzeng TF; Liou SS; Da Lin S; Wu MC; Liu IM
BMC Complement Altern Med; 2014 Mar; 14():110. PubMed ID: 24666993
[TBL] [Abstract][Full Text] [Related]
11. The anti-inflammatory and antifibrotic effects of Coreopsis tinctoria Nutt on high-glucose-fat diet and streptozotocin-induced diabetic renal damage in rats.
Yao L; Li L; Li X; Li H; Zhang Y; Zhang R; Wang J; Mao X
BMC Complement Altern Med; 2015 Sep; 15():314. PubMed ID: 26346939
[TBL] [Abstract][Full Text] [Related]
12. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
[TBL] [Abstract][Full Text] [Related]
13. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
14. Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats.
Ni WJ; Ding HH; Zhou H; Qiu YY; Tang LQ
Eur J Pharmacol; 2015 Oct; 764():448-456. PubMed ID: 26192633
[TBL] [Abstract][Full Text] [Related]
15. Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats.
Wang F; Li M; Cheng L; Zhang T; Hu J; Cao M; Zhao J; Guo R; Gao L; Zhang X
Life Sci; 2008 Dec; 83(25-26):828-35. PubMed ID: 18983856
[TBL] [Abstract][Full Text] [Related]
16. Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-κB and TGF-β1/Smad3 Signaling Pathways in Diabetic Nephropathy.
Zheng ZC; Zhu W; Lei L; Liu XQ; Wu YG
Drug Des Devel Ther; 2020; 14():4135-4148. PubMed ID: 33116403
[TBL] [Abstract][Full Text] [Related]
17. Renoprotective effects of oleanolic acid and its possible mechanisms in rats with diabetic kidney disease.
Liu Y; Hu Z; Xing H; Kang L; Chen X; Liu B; Niu K
Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):1-9. PubMed ID: 36332469
[TBL] [Abstract][Full Text] [Related]
18. Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy.
Li L; Emmett N; Mann D; Zhao X
Exp Biol Med (Maywood); 2010 Mar; 235(3):383-91. PubMed ID: 20404057
[TBL] [Abstract][Full Text] [Related]
19. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
[TBL] [Abstract][Full Text] [Related]
20. Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy.
Lang H; Dai C
Arch Med Res; 2016 Feb; 47(2):71-7. PubMed ID: 27018336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
